4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-20-002597
Options or other derivatives
- CEO acquired 176,414 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2020-01-06 | Grant or award · Stock Options (Right to Buy) | +138,304 | 138,304 | D | ||
| DAVIS STEPHEN CEO | 2020-01-06 | Grant or award · Restricted Stock Units | +38,110 | 38,110 | D | ||
Loading xslF345X03/doc4.xml…